# Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System

> **NCT03820713** · NA · COMPLETED · sponsor: **Eio Biomedical Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Reduction of Postoperative Adhesions

## Interventions

- **PROCEDURE:** Concentrate of plasma coagulation factors
- **PROCEDURE:** 0.9% saline

## Key facts

- **NCT ID:** NCT03820713
- **Lead sponsor:** Eio Biomedical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-09
- **Primary completion:** 2020-07-15
- **Final completion:** 2020-07-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03820713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03820713, "Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03820713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*